SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Kadmon Holdings (KDMN)

KDMN RSS Feed
Add KDMN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/21/2017 5:15:16 PM - Followers: 6 - Board type: Free - Posts Today: 0

Healthcare-Biotech company developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.
SureTrader
Interactive Brokers Advertisement
KDMN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
KDMN News: Current Report Filing (8-k) 10/06/2017 04:53:31 PM
KDMN News: FDA Grants Orphan Drug Designation to Kadmon’s KD025 for the Treatment of cGVHD 10/06/2017 08:11:00 AM
KDMN News: Statement of Ownership (sc 13g) 10/05/2017 04:34:40 PM
KDMN News: Amended Statement of Beneficial Ownership (sc 13d/a) 10/02/2017 04:47:02 PM
KDMN News: Kadmon Announces Closing of $80.4 Million Public Offerings and Full Exercise of Over-Allotment Option 09/28/2017 09:53:00 AM
PostSubject
#7   KDMN buy 3.56 stocktrademan 06/21/17 05:15:16 PM
#6   Watching T695 04/06/17 09:27:38 PM
#5   Another paper, all theory and in vitro work, mcp4 08/24/16 08:19:42 AM
#4   Preclinical paper for KD025, a ROCK2 inhibitor, for mcp4 08/21/16 01:59:57 AM
#3   Insider buying! Entered today. Good pipeline IMO. vortmaximum 07/28/16 07:09:03 PM
#2   KDMN IPO reduced to 6.3M shares at $12. mcp4 07/26/16 03:11:02 PM
#1   Kadmon shares are expected to price between $16 mcp4 07/26/16 09:17:55 AM
PostSubject